First‐line sorafenib sequential therapy and liver disease etiology for unresectable hepatocellular carcinoma using inverse probability weighting: A multicenter retrospective study

BACKGROUND AND AIMS: Sequential therapy with molecular‐targeted agents (MTAs) is considered effective for unresectable hepatocellular carcinoma (HCC) patients. This study purposed to evaluate the efficacy of sequential therapy with sorafenib (SORA) as a first‐line therapy and to investigate the ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimose, Shigeo, Hiraoka, Atsushi, Nakano, Masahito, Iwamoto, Hideki, Tanaka, Masatoshi, Tanaka, Takaaki, Noguchi, Kazunori, Aino, Hajime, Ogata, Kei, Kajiwara, Masahiko, Itano, Satoshi, Yokokura, Yoshinori, Yamaguchi, Taizo, Kawano, Hiroshi, Matsukuma, Norito, Suga, Hideya, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Okamura, Shusuke, Kawaguchi, Takumi, Koga, Hironori, Torimura, Takuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633265/
https://www.ncbi.nlm.nih.gov/pubmed/34693661
http://dx.doi.org/10.1002/cam4.4367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633265/
https://www.ncbi.nlm.nih.gov/pubmed/34693661
http://dx.doi.org/10.1002/cam4.4367

Ejemplares similares